CONCERT PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2022.
  • Concert Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $764K, a 2.97% increase year-over-year.
  • Concert Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $2.97M, a 23.4% increase from 2020.
  • Concert Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $2.41M, a 13.4% decline from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $764K +$22K +2.97% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 $742K +$498K +204% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $244K -$450K -64.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $694K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.